GMAB
Price
$32.47
Change
+$0.24 (+0.74%)
Updated
Sep 11 closing price
Capitalization
19.89B
54 days until earnings call
Intraday BUY SELL Signals
HALO
Price
$107.20
Change
+$0.20 (+0.19%)
Updated
Sep 11 closing price
Capitalization
12.16B
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMAB vs HALO

GMAB vs HALO Comparison Chart in %
View a ticker or compare two or three
VS
GMAB vs. HALO commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMAB is a Hold and HALO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMAB($19.9B) has a higher market cap than HALO($12.2B). HALO has higher P/E ratio than GMAB: HALO (31.43) vs GMAB (25.66). HALO YTD gains are higher at: 59.287 vs. GMAB (5.422). GMAB has higher annual earnings (EBITDA): 1.27B vs. HALO (718M). GMAB has more cash in the bank: 1.5B vs. HALO (231M). HALO has less debt than GMAB: HALO (2.15B) vs GMAB (5.27B). GMAB has higher revenues than HALO: GMAB (4.13B) vs HALO (1.66B).
GMABHALOGMAB / HALO
Capitalization19.9B12.2B163%
EBITDA1.27B718M177%
Gain YTD5.42259.2879%
P/E Ratio25.6631.4382%
Revenue4.13B1.66B248%
Total Cash1.5B231M651%
Total Debt5.27B2.15B246%
FUNDAMENTALS RATINGS
GMAB vs HALO: Fundamental Ratings
GMAB
HALO
OUTLOOK RATING
1..100
8079
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10018
SMR RATING
1..100
5911
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMAB's Valuation (86) in the null industry is in the same range as HALO (89) in the Biotechnology industry. This means that GMAB’s stock grew similarly to HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (18) in the Biotechnology industry is significantly better than the same rating for GMAB (100) in the null industry. This means that HALO’s stock grew significantly faster than GMAB’s over the last 12 months.

HALO's SMR Rating (11) in the Biotechnology industry is somewhat better than the same rating for GMAB (59) in the null industry. This means that HALO’s stock grew somewhat faster than GMAB’s over the last 12 months.

HALO's Price Growth Rating (36) in the Biotechnology industry is in the same range as GMAB (40) in the null industry. This means that HALO’s stock grew similarly to GMAB’s over the last 12 months.

HALO's P/E Growth Rating (9) in the Biotechnology industry is in the same range as GMAB (9) in the null industry. This means that HALO’s stock grew similarly to GMAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMABHALO
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
63%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 4 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
75%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (GMAB: $32.47 vs. HALO: $107.20)
Brand notoriety: GMAB and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GMAB: 65% vs. HALO: 51%
Market capitalization -- GMAB: $19.89B vs. HALO: $12.16B
GMAB [@Biotechnology] is valued at $19.89B. HALO’s [@Biotechnology] market capitalization is $12.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMAB’s FA Score shows that 1 FA rating(s) are green while HALO’s FA Score has 3 green FA rating(s).

  • GMAB’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 3 green, 2 red.
According to our system of comparison, HALO is a better buy in the long-term than GMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMAB’s TA Score shows that 5 TA indicator(s) are bullish while HALO’s TA Score has 3 bullish TA indicator(s).

  • GMAB’s TA Score: 5 bullish, 4 bearish.
  • HALO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GMAB is a better buy in the short-term than HALO.

Price Growth

GMAB (@Biotechnology) experienced а -3.36% price change this week, while HALO (@Biotechnology) price change was -2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

GMAB is expected to report earnings on Nov 05, 2026.

HALO is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
GMAB
Daily Signal:
Gain/Loss:
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRWD4.080.11
+2.77%
Ironwood Pharmaceuticals
FICO985.3924.72
+2.57%
Fair Isaac Corp
PVH70.641.29
+1.86%
PVH Corp
BYFC11.81-0.04
-0.34%
Broadway Financial Corp
WBUY0.87-0.05
-4.92%
Webuy Global Ltd

GMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
+0.74%
AXON - GMAB
47%
Loosely correlated
+0.10%
RYTM - GMAB
41%
Loosely correlated
+2.46%
LKFT - GMAB
40%
Loosely correlated
N/A
HALO - GMAB
38%
Loosely correlated
+0.19%
BCAX - GMAB
38%
Loosely correlated
-1.26%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.19%
AXON - HALO
47%
Loosely correlated
+0.10%
INCY - HALO
39%
Loosely correlated
-1.47%
GMAB - HALO
38%
Loosely correlated
+0.74%
VRTX - HALO
37%
Loosely correlated
+0.17%
ONC - HALO
35%
Loosely correlated
+1.38%
More